SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-19-214685
Filing Date
2019-08-07
Accepted
2019-08-07 08:24:32
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-3 d782307df3.htm F-3 371509
2 EX-4.1 d782307dex41.htm EX-4.1 161697
3 EX-4.2 d782307dex42.htm EX-4.2 299599
4 EX-4.5 d782307dex45.htm EX-4.5 122586
5 EX-4.6 d782307dex46.htm EX-4.6 108612
6 EX-5.1 d782307dex51.htm EX-5.1 28287
7 EX-5.2 d782307dex52.htm EX-5.2 19116
8 EX-23.1 d782307dex231.htm EX-23.1 3131
9 GRAPHIC g782307g0806084133491.jpg GRAPHIC 1869
10 GRAPHIC g782307g18p96.jpg GRAPHIC 43809
11 GRAPHIC g782307g71t91.jpg GRAPHIC 3310
  Complete submission text file 0001193125-19-214685.txt   1183261
Mailing Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228
Business Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228 0041-0-22-552-1558
ObsEva SA (Filer) CIK: 0001685316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-233069 | Film No.: 191003922
SIC: 2834 Pharmaceutical Preparations